A PYMNTS Company

Australia: ACCC approves giant pharmaceutical merger

By  |  September 20, 2018

The ACCC has announced that it will not oppose the merger of generics companies Arrow and Apotex. Once combined, the two companies would supply around half the market for generic prescription pharmaceuticals to pharmacies in Australia.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    The announcement that Strides Pharma Science Ltd and Apotex Inc planned to merge Arrow Pharmaceuticals and Apotex Australia was made on May 18, 2018.

    The ACCC says that after market inquiries and analysis of documents and data, the ACCC considers that the merger will not substantially reduce competition in any market.

    Full Content: AJP

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.